EH
BIIB icon

Equitable Holdings’s Biogen BIIB Stock Holding History

Equitable Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,275
Closed -$247K – 1270
2024
Q3 		$247K Sell
1,275
-2
-0.2% -$418 ﹤0.01% 1107
2024
Q2 		$296K Buy
1,277
+64
+5% +$13.9K ﹤0.01% 997
2024
Q1 		$262K Buy
1,213
+124
+11% +$29K ﹤0.01% 1000
2023
Q4 		$282K Buy
1,089
+190
+21% +$46.7K ﹤0.01% 959
2023
Q3 		$231K Sell
899
-86
-9% -$23K ﹤0.01% 956
2023
Q2 		$281K Buy
+985
New +$293K ﹤0.01% 870
2020
Q4 		– Sell
-1,059
Closed -$300K – 680
2020
Q3 		$300K Buy
+1,059
New +$295K 0.01% 515

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Equitable Holdings's BIIB Position: Q4 2024 in Review

Equitable Holdings sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,275 shares — an estimated $247K sold.

Equitable Holdings first reported a position in BIIB in Q3 2020 and held it in 7 quarters. The position peaked at $300K in Q3 2020. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Equitable Holdings reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Equitable Holdings sold 1,275 Biogen shares in Q4 2024, an estimated $247K.
  • Equitable Holdings first reported a position in Biogen in Q3 2020 and held it in 7 quarters.
  • Equitable Holdings's Biogen position peaked at $300K in Q3 2020.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Equitable Holdings's 13F filing for Q4 2024, filed 12 Feb 2025.